Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Neurotoxicology. 2021 Jul 2;86:26–36. doi: 10.1016/j.neuro.2021.06.008

Figure 10. Tau mRNA and protein levels in differentiated SH-SY5Y cells after PFOS exposure (tau pathway).

Figure 10.

Differentiated SH-SY5Y cells exposed to PFOS at 0.001 and 0.1 μM concentrations for 24 h. (A, D) Blots and quantification of Tau protein levels normalized to GAPDH. (E) Tau mRNA levels. (B, F) Blots and quantification of p-tau (ser404) protein levels normalized to GAPDH. (C, G) Blots and quantification of p-tau (Thr 181) protein levels normalized to GAPDH. Results are expressed as mean ± S.E.M using the one-way ANOVA followed by Dunnett’s for multiple comparisons n=3 per treatment group (*P< 0.05, **P< 0.01).